mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.1 |
mRNA |
BMS-754807 |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.1 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
OSI-027 |
GDSC1000 |
pan-cancer |
AAC |
-0.051 |
0.1 |
mRNA |
Talazoparib |
GDSC1000 |
pan-cancer |
AAC |
0.054 |
0.1 |
mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
-0.051 |
0.1 |
mRNA |
ABT-888 |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.1 |
mRNA |
Tipifarnib |
GDSC1000 |
pan-cancer |
AAC |
0.057 |
0.1 |
mRNA |
PF-4800567 hydrochloride |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.1 |